PortfoliosLab logoPortfoliosLab logo
XRP-USD vs. VRTX
Performance
Return for Risk
Drawdowns
Volatility

Performance

XRP-USD vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XRP (XRP-USD) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XRP-USD achieves a -37.47% return, which is significantly lower than VRTX's -1.86% return.


XRP-USD

1D
1.46%
1M
-22.57%
YTD
-37.47%
6M
-43.16%
1Y
-46.47%
3Y*
33.79%
5Y*
5.19%
10Y*

VRTX

1D
-0.03%
1M
-1.22%
YTD
-1.86%
6M
-1.57%
1Y
-2.31%
3Y*
9.16%
5Y*
18.18%
10Y*
17.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XRP-USD vs. VRTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XRP-USD
XRP
-37.47%-11.56%237.88%81.04%-59.10%278.06%13.98%-45.31%-84.67%38,242.83%
VRTX
Vertex Pharmaceuticals Incorporated
-1.86%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%

Correlation

The correlation between XRP-USD and VRTX is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2017

0.06

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XRP-USD vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XRP-USD
XRP-USD Risk / Return Rank: 5858
Overall Rank
XRP-USD Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
XRP-USD Sortino Ratio Rank: 5656
Sortino Ratio Rank
XRP-USD Omega Ratio Rank: 5454
Omega Ratio Rank
XRP-USD Calmar Ratio Rank: 6868
Calmar Ratio Rank
XRP-USD Martin Ratio Rank: 6060
Martin Ratio Rank

VRTX
VRTX Risk / Return Rank: 3737
Overall Rank
VRTX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 3434
Sortino Ratio Rank
VRTX Omega Ratio Rank: 3535
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3838
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XRP-USD vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XRP (XRP-USD) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XRP-USDVRTXDifference
Sharpe ratioReturn per unit of total volatility

-0.59

Sortino ratioReturn per unit of downside risk

-0.96

Omega ratioGain probability vs. loss probability

0.91

1.02

-0.10

Calmar ratioReturn relative to maximum drawdown

-0.67

-0.14

-0.53

Martin ratioReturn relative to average drawdown

-1.06

-0.29

-0.76

XRP-USD vs. VRTX - Sharpe Ratio Comparison

The current XRP-USD Sharpe Ratio is -0.69, which is lower than the VRTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of XRP-USD and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XRP-USD vs. VRTX - Drawdown Comparison

The maximum XRP-USD drawdown since its inception was -95.87%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for XRP-USD and VRTX.


Loading charts...

Drawdown Indicators


XRP-USDVRTXDifference

Max Drawdown

Largest peak-to-trough decline

-95.87%

-91.77%

-4.10%

Max Drawdown (1Y)

Largest decline over 1 year

-69.23%

-23.56%

-45.67%

Max Drawdown (3Y)

Largest decline over 3 years

-69.23%

-29.07%

-40.16%

Max Drawdown (5Y)

Largest decline over 5 years

-77.83%

-29.07%

-48.76%

Max Drawdown (10Y)

Largest decline over 10 years

-41.60%

Current Drawdown

Current decline from peak

-67.62%

-13.90%

-53.72%

Average Drawdown

Average peak-to-trough decline

-70.99%

-37.73%

-33.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

43.98%

11.30%

+32.68%

Volatility

XRP-USD vs. VRTX - Volatility Comparison

XRP (XRP-USD) has a higher volatility of 14.05% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that XRP-USD's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XRP-USDVRTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.05%

7.47%

+6.58%

Volatility (6M)

Calculated over the trailing 6-month period

46.30%

20.71%

+25.59%

Volatility (1Y)

Calculated over the trailing 1-year period

56.19%

34.13%

+22.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.34%

28.53%

+43.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.77%

32.82%

+78.95%

Frequently Asked Questions


XRP-USD and VRTX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XRP-USD has higher volatility (14.05%) compared to VRTX (7.47%). In terms of maximum drawdown, XRP-USD dropped -95.87% vs VRTX's -91.77%.

VRTX currently has the higher Sharpe Ratio (-0.10 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XRP-USD and VRTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer